NDC 36000-364-01
regadenoson .08 mg/mL
regadenoson · INJECTION, SOLUTION
Regadenoson is an injectable medication that works by stimulating adenosine receptors and is used during cardiac stress testing to help evaluate how well your heart is working. It's administered intravenously by a healthcare provider as part of a diagnostic procedure to assess blood flow to the heart muscle.
Key Facts
- Brand Name
- regadenoson
- Generic Name
- regadenoson
- NDC Code (Package)
36000-364-01- NDC Code (Product)
36000-364- Manufacturer
- Baxter Healthcare Corporation
- Strength
- .08 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- ANDA217455
- Drug Class
- Adenosine Receptor Agonist [EPC]
- Marketing Start
- 05/23/2023
Recall History
No Recall HistoryView Full Drug Page
regadenoson — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.